Workflow
IGC Pharma(IGC) - 2026 Q1 - Quarterly Report
IGC PharmaIGC Pharma(US:IGC)2025-08-14 20:04

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Exact name of registrant as specified in its charter) FORM 10-Q ☑ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2025 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission file number: 001-32830 IGC PHARMA, INC. | Maryland | 20-2760393 | | --- | --- | | (State or other jurisdiction | (I.R.S. Employer | | of i ...